In vitro activity of ponazuril against Theileria equi.

The research investigates the effectiveness of the anti-protozoal drug, ponazuril, in curtailing the replication of the parasite Theileria equi, which infects horses and leads to considerable economic setback on account of the associated disease and restrictions on trade. Although in vitro tests showed ponazuril did inhibit T.equ i at all concentrations, a high dosage was necessary for complete eradication, bringing into question its potential use for in vivo application.

Background of The Study

• The study revolves around the hemoprotozoan parasite Theileria equi, which is the root cause of significant economic loss by infecting horses, resulting in disease and curtailing trade with non-endemic regions.
• The effectiveness of certain drugs, like imidocarb dipropionate, in eradicating persistent T. equi infection and reducing transmission risk is debated among researchers.
• The research explores the potential of the anti-protozoal agent ponazuril, which has been effectively used earlier against equine Sarcosystis neurona and Toxoplasma gondii, to inhibit T.equ i.

Hypothesis and Testing

• The research hypothesizes that ponazuril could inhibit the replication of T. equi in vitro.
• The hypothesis was tested on T. equi infected equine erythrocyte cultures treated with multiple concentrations of ponazuril.
• Observations were made over a five-day period to record the cessation of parasite replication and the degree of inhibition achieved at variable drug concentrations.

Findings and Conclusions

• The research discovered that ponazuril can indeed inhibit T. equi in equine erythrocyte cultures at all tested concentrations, but elimination of the parasite required a relatively high dose of at least 500 μg/mL.
• However, the requirement of such high dosages for in vitro inhibition might limit the drug’s application for controlling or clearing T. equi infection in vivo in real-life scenarios.
• Additional research is recommended to evaluate related drugs with potential effectiveness against T. equi.